Clinical Minds https://www.medidata.com/en/the-latest-on-covid-19 en Medidata Go behind the scenes of clinical research with some of the leading minds in life sciences. Discover what’s happening in today’s world of clinical trials, the technology and ideas transforming them, and why it matters for each and every one of us. This is Clinical Minds, presented by Medidata. https://megaphone.imgix.net/podcasts/153dcb24-1d3e-11ed-94ea-83f9626efb7f/image/5640203-1617728858657-1bb03742d27a8.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Clinical Minds https://www.medidata.com/en/the-latest-on-covid-19 no episodic Medidata Go behind the scenes of clinical research with some of the leading minds in life sciences. Discover what’s happening in today’s world of clinical trials, the technology and ideas transforming them, and why it matters for each and every one of us. This is Clinical Minds, presented by Medidata. Go behind the scenes of clinical research with some of the leading minds in life sciences. Discover what’s happening in today’s world of clinical trials, the technology and ideas transforming them, and why it matters for each and every one of us. This is Clinical Minds, presented by Medidata.

]]> Medidata medidata@healthpodcastnetwork.com Adopting Clinical Trial Technology: The Key to Success for Patients, Sites, & Researchers Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials. In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Irfan Khan, MD, founder and CEO of Circuit Clinical, to discuss clinical trial technology adoption across patients, care teams, trial sites, and researchers and the need for industry buy-in, especially around decentralized trial technology. Dr. Khan is a cardiologist who has served as a principal investigator on both therapeutic and device clinical trials for more than a decade. He is passionate about improving diversity in clinical trials, increasing community engagement, and fostering the patient experience through education and empowerment. Over the last six years, he has overseen Circuit Clinical’s growth to reach more than 2.5 million potential participants across 60+ active research sites. Fri, 02 Dec 2022 05:00:00 -0000 full Medidata Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials. In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Irfan Khan, MD, founder and CEO of Circuit Clinical, to discuss clinical trial technology adoption across patients, care teams, trial sites, and researchers and the need for industry buy-in, especially around decentralized trial technology. Dr. Khan is a cardiologist who has served as a principal investigator on both therapeutic and device clinical trials for more than a decade. He is passionate about improving diversity in clinical trials, increasing community engagement, and fostering the patient experience through education and empowerment. Over the last six years, he has overseen Circuit Clinical’s growth to reach more than 2.5 million potential participants across 60+ active research sites. Adoption of new clinical trial technologies is critical to success. These innovations can lift patient burden, improve patient engagement, and increase equity and access to clinical trials.


In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Irfan Khan, MD, founder and CEO of Circuit Clinical, to discuss clinical trial technology adoption across patients, care teams, trial sites, and researchers and the need for industry buy-in, especially around decentralized trial technology.


Dr. Khan is a cardiologist who has served as a principal investigator on both therapeutic and device clinical trials for more than a decade. He is passionate about improving diversity in clinical trials, increasing community engagement, and fostering the patient experience through education and empowerment. Over the last six years, he has overseen Circuit Clinical’s growth to reach more than 2.5 million potential participants across 60+ active research sites.

]]> 1459 Clinical Trial Patient Recruitment: One Size Does Not Fit All When it comes to patient recruitment strategies, there is no one-size-fits-all approach. So how do you raise clinical trial awareness and develop innovative solutions for recruitment that break down silos and improve patient outreach? In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Tricia Barrett, Chief Operating Officer at Praxis & Crowley Webb, to discuss what an efficient direct-to-patient recruitment campaign looks like. Learn how to drive diverse patient recruitment by moving from transactional, traditional strategies to innovative, people-focused approaches. Tricia oversees all Praxis operations from proposal generation through completed, enrolled studies. Her experience encompasses a wide range of therapeutic areas and strategies. Tricia brings a unique approach to patient recruitment that focuses on sound science and innovative execution, while always keeping the patient experience top of mind. Thu, 27 Oct 2022 12:05:00 -0000 full Medidata When it comes to patient recruitment strategies, there is no one-size-fits-all approach. So how do you raise clinical trial awareness and develop innovative solutions for recruitment that break down silos and improve patient outreach? In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Tricia Barrett, Chief Operating Officer at Praxis & Crowley Webb, to discuss what an efficient direct-to-patient recruitment campaign looks like. Learn how to drive diverse patient recruitment by moving from transactional, traditional strategies to innovative, people-focused approaches. Tricia oversees all Praxis operations from proposal generation through completed, enrolled studies. Her experience encompasses a wide range of therapeutic areas and strategies. Tricia brings a unique approach to patient recruitment that focuses on sound science and innovative execution, while always keeping the patient experience top of mind. When it comes to patient recruitment strategies, there is no one-size-fits-all approach. So how do you raise clinical trial awareness and develop innovative solutions for recruitment that break down silos and improve patient outreach?


In this episode, Kelly McKee and Alicia Staley of Medidata are joined by Tricia Barrett, Chief Operating Officer at Praxis & Crowley Webb, to discuss what an efficient direct-to-patient recruitment campaign looks like. Learn how to drive diverse patient recruitment by moving from transactional, traditional strategies to innovative, people-focused approaches.


Tricia oversees all Praxis operations from proposal generation through completed, enrolled studies. Her experience encompasses a wide range of therapeutic areas and strategies. Tricia brings a unique approach to patient recruitment that focuses on sound science and innovative execution, while always keeping the patient experience top of mind.

]]> 2348 The Power of Patient Insights: Solutions Designed Side-by-Side with Patients Is your product truly inspired by patient insights? Patient centricity is more than just a buzzword: it’s a movement. So how do you make sure your products improve the patient experience in clinical trials and alleviate patient burden? In this episode, industry experts Kelly McKee and Alicia Staley are joined by Paul Chang, VP of Design at Medidata, to map the future of product design in clinical trials. Learn how Medidata’s patient advocates directly impact UX design to drive patient centricity across products. Paul has spent over 20 years across a diverse range of product and design initiatives. In his role as VP of Design, he is responsible for how products and services are experienced by customers, partners, clinicians, and patients; this includes leading design strategy and building Medidata’s capabilities and reputation as a design-driven company. Tue, 11 Oct 2022 20:31:00 -0000 full 3 2 Medidata Is your product truly inspired by patient insights? Patient centricity is more than just a buzzword: it’s a movement. So how do you make sure your products improve the patient experience in clinical trials and alleviate patient burden? In this episode, industry experts Kelly McKee and Alicia Staley are joined by Paul Chang, VP of Design at Medidata, to map the future of product design in clinical trials. Learn how Medidata’s patient advocates directly impact UX design to drive patient centricity across products. Paul has spent over 20 years across a diverse range of product and design initiatives. In his role as VP of Design, he is responsible for how products and services are experienced by customers, partners, clinicians, and patients; this includes leading design strategy and building Medidata’s capabilities and reputation as a design-driven company. Is your product truly inspired by patient insights? Patient centricity is more than just a buzzword: it’s a movement. So how do you make sure your products improve the patient experience in clinical trials and alleviate patient burden?


In this episode, industry experts Kelly McKee and Alicia Staley are joined by Paul Chang, VP of Design at Medidata, to map the future of product design in clinical trials. Learn how Medidata’s patient advocates directly impact UX design to drive patient centricity across products.


Paul has spent over 20 years across a diverse range of product and design initiatives. In his role as VP of Design, he is responsible for how products and services are experienced by customers, partners, clinicians, and patients; this includes leading design strategy and building Medidata’s capabilities and reputation as a design-driven company.

]]> 1030 Give Me My Data: How Patient Access Builds Trust in Clinical Trials As a patient, who owns your clinical trial data? Patient participation is the foundation of clinical trial research. But in today’s world, patient access to data is limited and siloed. How do researchers ensure patient data return is the standard operating procedure and information is shared with trial participants? In this episode, Craig Lipset sits down with Kelly McKee and Alicia Staley of Medidata to discuss the challenges of data return and how to improve patient access and clinical trial data transparency. Craig is an advisor, educator, advocate, and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, Co-Chair for the Decentralized Trials & Research Alliance, and Vice Chair of the MedStar Health Research Institute.  Wed, 21 Sep 2022 04:00:00 -0000 Give Me My Data: How Patient Access Builds Trust in Clinical Trials full 3 1 Medidata As a patient, who owns your clinical trial data? Patient participation is the foundation of clinical trial research. But in today’s world, patient access to data is limited and siloed. How do researchers ensure patient data return is the standard operating procedure and information is shared with trial participants? In this episode, Craig Lipset sits down with Kelly McKee and Alicia Staley of Medidata to discuss the challenges of data return and how to improve patient access and clinical trial data transparency. Craig is an advisor, educator, advocate, and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, Co-Chair for the Decentralized Trials & Research Alliance, and Vice Chair of the MedStar Health Research Institute.  As a patient, who owns your clinical trial data? Patient participation is the foundation of clinical trial research. But in today’s world, patient access to data is limited and siloed. How do researchers ensure patient data return is the standard operating procedure and information is shared with trial participants?

In this episode, Craig Lipset sits down with Kelly McKee and Alicia Staley of Medidata to discuss the challenges of data return and how to improve patient access and clinical trial data transparency.

Craig is an advisor, educator, advocate, and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, Co-Chair for the Decentralized Trials & Research Alliance, and Vice Chair of the MedStar Health Research Institute. 

]]> 1465 no How the FDA is focused on improving clinical trial access, enrollment, and enhancing public trust and education https://anchor.fm/clinicalminds/episodes/How-the-FDA-is-focused-on-improving-clinical-trial-access--enrollment--and-enhancing-public-trust-and-education-e1bp0rm The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity. Related links https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity https://www.beaconpublichealth.com/ Wed, 15 Dec 2021 20:22:04 -0000 full 2 4 Medidata <p>The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.</p> <p><br></p> <p>Related links</p> <p><a href="https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity"><u>https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity</u></a></p> <p><a href="https://www.beaconpublichealth.com/"><u>https://www.beaconpublichealth.com/</u></a></p> The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity. Related links https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity https://www.beaconpublichealth.com/ The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.


Related links

https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity

https://www.beaconpublichealth.com/

]]> 1682 no How to better bridge the gaps in Latinx patients clinical trial participation with Dr. Fabian Sandoval https://anchor.fm/clinicalminds/episodes/How-to-better-bridge-the-gaps-in-Latinx-patients-clinical-trial-participation-with-Dr--Fabian-Sandoval-e1beae4 The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia Wed, 08 Dec 2021 19:00:00 -0000 full 2 3 Medidata <p>The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia</p> The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia The simplest thing to do is to find out what kind of patients you have. Find out what cultures they are. Learn about the culture. Learn to connect. Be a human. Don't just be a robot that does science. Don't speak above someone's level. Speak to them. Put yourself in that patient's shoes, and speak to them kindly,” says Dr. Fabian Sandoval, CEO and Research Director of the Emerson Clinical Research Institute in Washington, DC, and Emmy winner and host of the weekly medical TV show "Tu Salud, Tu Familia

]]> 1057 no The importance of community building, patient trust, and improving access to cancer clinical trials with Dana Dornsife https://anchor.fm/clinicalminds/episodes/The-importance-of-community-building--patient-trust--and-improving-access-to-cancer-clinical-trials-with-Dana-Dornsife-e1b3cc2 Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006. Wed, 01 Dec 2021 18:00:00 -0000 full 2 2 Medidata <p>Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006.</p> Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006. Currently our black and brown communities are really grossly underrepresented in cancer clinical trials, and we need to fix that. Historical barriers around egregious medical behaviors that have taken place in the past, cultural barriers, language barriers, and finally socioeconomic barriers impact the outcome of someone’s cancer journey,” says Dana Dornsife, founder and CEO at Lazarex Cancer Foundation, a nationwide non-profit org she founded in 2006.

]]> 1480 no A brief history of inequity in the practice of medicine & medical experimentation with Harriet A. Washington https://anchor.fm/clinicalminds/episodes/A-brief-history-of-inequity-in-the-practice-of-medicine--medical-experimentation-with-Harriet-A--Washington-e1anarn A lot has to do with the ability to admit the painful truth about American racism in healthcare and then to make the equally painful changes that it requires,” says Harriet A. Washington, medical ethicist, American writer, and the author of Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present and Carte Blanche Wed, 24 Nov 2021 12:00:00 -0000 full 2 1 Medidata <p>A lot has to do with the ability to admit the painful truth about American racism in healthcare and then to make the equally painful changes that it requires,” says Harriet A. Washington, medical ethicist, American writer, and the author of Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present and Carte Blanche</p> A lot has to do with the ability to admit the painful truth about American racism in healthcare and then to make the equally painful changes that it requires,” says Harriet A. Washington, medical ethicist, American writer, and the author of Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present and Carte Blanche A lot has to do with the ability to admit the painful truth about American racism in healthcare and then to make the equally painful changes that it requires,” says Harriet A. Washington, medical ethicist, American writer, and the author of Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present and Carte Blanche

]]> 1516 no Introducing Season 2: Diversity in Clinical Trials https://anchor.fm/clinicalminds/episodes/Introducing-Season-2-Diversity-in-Clinical-Trials-e1a4hbp Introducing Season 2 of Clinical Minds! An entire season dedicated to why diversity in clinical trials is so important and what’s being done to improve participation among underrepresented populations. To kick things off, host Paul Oestreicher chats with Jackie Kent, evp and chief customer officer at Medidata, a Dassault Systèmes Thu, 11 Nov 2021 20:00:00 -0000 trailer 2 Medidata <p>Introducing Season 2 of Clinical Minds! An entire season dedicated to why diversity in clinical trials is so important and what’s being done to improve participation among underrepresented populations.</p> <p>To kick things off, host Paul Oestreicher chats with Jackie Kent, evp and chief customer officer at Medidata, a Dassault Systèmes</p> Introducing Season 2 of Clinical Minds! An entire season dedicated to why diversity in clinical trials is so important and what’s being done to improve participation among underrepresented populations. To kick things off, host Paul Oestreicher chats with Jackie Kent, evp and chief customer officer at Medidata, a Dassault Systèmes Introducing Season 2 of Clinical Minds! An entire season dedicated to why diversity in clinical trials is so important and what’s being done to improve participation among underrepresented populations.

To kick things off, host Paul Oestreicher chats with Jackie Kent, evp and chief customer officer at Medidata, a Dassault Systèmes

]]> 100 no What is a patient equation? https://anchor.fm/clinicalminds/episodes/What-is-a-patient-equation-ehc42b Glen de Vries, co-founder and co CEO of Medidata and author of the upcoming book, The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond on how to bring together everything learned about COVID-19 to find treatments and vaccines and what can be done to make sure something like this doesn't happen again. Wed, 29 Jul 2020 10:00:00 -0000 full 1 6 Medidata <p>Glen de Vries, co-founder and co CEO of Medidata and author of the upcoming book, <em>The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond </em>on how to bring together everything learned about COVID-19 to find treatments and vaccines and what can be done to make sure something like this doesn't happen again.</p> Glen de Vries, co-founder and co CEO of Medidata and author of the upcoming book, The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond on how to bring together everything learned about COVID-19 to find treatments and vaccines and what can be done to make sure something like this doesn't happen again. Glen de Vries, co-founder and co CEO of Medidata and author of the upcoming book, The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond on how to bring together everything learned about COVID-19 to find treatments and vaccines and what can be done to make sure something like this doesn't happen again.

]]> 675 no What if a treatment already exists? https://anchor.fm/clinicalminds/episodes/What-if-a-treatment-already-exists-egoip6 Dr. David Fajgenbaum, physician, scientist and author of the bestselling memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action, on his approach to drug repurposing, how he and a team of volunteers have been applying this approach to Covid-19, and why this gives hope for all diseases with unmet need. Wed, 15 Jul 2020 09:00:00 -0000 full 1 5 Medidata <p>Dr. David Fajgenbaum, physician, scientist and author of the bestselling memoir, <em>Chasing My Cure: A Doctor's Race to Turn Hope Into Action</em>, on his approach to drug repurposing, how he and a team of volunteers have been applying this approach to Covid-19, and why this gives hope for all diseases with unmet need.</p> Dr. David Fajgenbaum, physician, scientist and author of the bestselling memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action, on his approach to drug repurposing, how he and a team of volunteers have been applying this approach to Covid-19, and why this gives hope for all diseases with unmet need. Dr. David Fajgenbaum, physician, scientist and author of the bestselling memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action, on his approach to drug repurposing, how he and a team of volunteers have been applying this approach to Covid-19, and why this gives hope for all diseases with unmet need.

]]> 885 no What is the data telling us? https://anchor.fm/clinicalminds/episodes/What-is-the-data-telling-us-egeon0 Fareed Melhem, head of Acorn AI Labs, on what data trends reveal about Covid-19's global impact on clinical research, and how data science is being used to overcome challenges created by the pandemic. Wed, 08 Jul 2020 09:00:00 -0000 full 1 4 Medidata <p>Fareed Melhem, head of Acorn AI Labs, on what data trends reveal about Covid-19's global impact on clinical research, and how data science is being used to overcome challenges created by the pandemic.</p> Fareed Melhem, head of Acorn AI Labs, on what data trends reveal about Covid-19's global impact on clinical research, and how data science is being used to overcome challenges created by the pandemic. Fareed Melhem, head of Acorn AI Labs, on what data trends reveal about Covid-19's global impact on clinical research, and how data science is being used to overcome challenges created by the pandemic.

]]> 714 no What do virtual clinical trials look like? https://anchor.fm/clinicalminds/episodes/What-do-virtual-clinical-trials-look-like-eg4k36 Anthony Costello, senior vice president of mobile health at Medidata, on what clinical trials look like when people are unable or unwilling to leave home, what this means for the race for a vaccine, and how mobile health technology is paving the way. Wed, 01 Jul 2020 13:00:00 -0000 full 1 3 Medidata <p>Anthony Costello, senior vice president of mobile health at Medidata, on what clinical trials look like when people are unable or unwilling to leave home, what this means for the race for a vaccine, and how mobile health technology is paving the way.</p> Anthony Costello, senior vice president of mobile health at Medidata, on what clinical trials look like when people are unable or unwilling to leave home, what this means for the race for a vaccine, and how mobile health technology is paving the way. Anthony Costello, senior vice president of mobile health at Medidata, on what clinical trials look like when people are unable or unwilling to leave home, what this means for the race for a vaccine, and how mobile health technology is paving the way.

]]> 768 no How do we keep clinical trial patients safe in a pandemic? https://anchor.fm/clinicalminds/episodes/How-do-we-keep-clinical-trial-patients-safe-in-a-pandemic-efqlfj How drugs go from a lab, to testing in humans, to your local pharmacy. Here's what’s happening in the world of clinical research today, the technology and ideas that are transforming it, and why this matters for patients. Which is all of us. Presented by Medidata. Wed, 24 Jun 2020 13:00:00 -0000 full 1 2 Medidata <p>How&nbsp;drugs&nbsp;go&nbsp;from a&nbsp;lab, to&nbsp;testing&nbsp;in&nbsp;humans, to&nbsp;your&nbsp;local&nbsp;pharmacy.&nbsp;Here's&nbsp;what’s&nbsp;happening&nbsp;in the&nbsp;world&nbsp;of&nbsp;clinical&nbsp;research&nbsp;today, the&nbsp;technology&nbsp;and&nbsp;ideas&nbsp;that are&nbsp;transforming&nbsp;it, and why this&nbsp;matters&nbsp;for&nbsp;patients. Which is&nbsp;all&nbsp;of&nbsp;us.&nbsp;<a href="http://www.medidata.com/" target="_blank">Presented by Medidata</a>.</p> How drugs go from a lab, to testing in humans, to your local pharmacy. Here's what’s happening in the world of clinical research today, the technology and ideas that are transforming it, and why this matters for patients. Which is all of us. Presented by Medidata. How drugs go from a lab, to testing in humans, to your local pharmacy. Here's what’s happening in the world of clinical research today, the technology and ideas that are transforming it, and why this matters for patients. Which is all of us. Presented by Medidata.

]]> 488 no When will we get the vaccine? https://anchor.fm/clinicalminds/episodes/When-will-we-get-the-vaccine-ef6lgb Clinical trials 101. Alicia Staley, director of patient engagement at Medidata, on why it takes so long to develop drugs and vaccines, what clinical trials are, and how clinical trials can do better for patients. Tue, 09 Jun 2020 15:17:28 -0000 full 1 1 Medidata <p>Clinical&nbsp;trials 101. Alicia Staley, director of patient engagement at Medidata, on why it takes so long to develop&nbsp;drugs&nbsp;and vaccines, what&nbsp;clinical&nbsp;trials are, and how&nbsp;clinical&nbsp;trials can do better for&nbsp;patients.</p> Clinical trials 101. Alicia Staley, director of patient engagement at Medidata, on why it takes so long to develop drugs and vaccines, what clinical trials are, and how clinical trials can do better for patients. Clinical trials 101. Alicia Staley, director of patient engagement at Medidata, on why it takes so long to develop drugs and vaccines, what clinical trials are, and how clinical trials can do better for patients.

]]> 796 no